Intra-individual comparison of sentinel lymph node scintigraphy on the day of injection and on the following day in breast cancer

Nuclear Medicine Communications

Volumn 27, Issue 1, 2006, Pages 5-9

  Gutman, Fabrice ^a   Sanson, Agathe ^b   Piquenot, Jean Michel ^c   Hitzel, Anne ^c   Ladonne, Jean Marie ^c   Dessogne, Phillipe ^c   Véra, Pierre ^c  

^a HÔPITAL CHARLES NICOLLE   (France)

^b Laboratoire universitaire QUANTIF   (France)

^c CENTRE HENRI BECQUEREL   (France)

Author keywords

Breast cancer; Sentinel node imaging

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INDIVIDUALITY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE; BREAST TUMOR; IMAGE ENHANCEMENT; INJECTION; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TIME;

BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; OBSERVER VARIATION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID; TIME FACTORS;

EID: 33645229004     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000189781.62282.0d     Document Type: Article

References (18)

1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66:136-138.
2. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 1997; 33:193-199.
3. Goldfarb LR, Alazraki NP, Eshima D, Eshima LA, Herda SC, Halkar RK. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid. Radiology 1998; 208:505-509.
4. Valdes Olmos RA, Tanis PJ, Hoefnagel CA, Nieweg OE, Muller SH, Rutgers EJ, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22:579-586.
5. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998; 339:941-946.
6. Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 2000; 180:434-437; discussion 437-438.
7. Zavagno G, Meggiolaro F, Rossi CR, Casara D, Pescarini L, Marchet A, et al. Subareolar injection for sentinel lymph node location in breast cancer. Eur J Surg Oncol 2002; 28:701-704.
8. Shen P, Glass EC, DiFronzo LA, Giuliano AE. Dermal versus intraparenchymal lymphoscintigraphy of the breast. Ann Surg Oncol 2001; 8:241-248.
9. Yoshida K, Yamamoto N, Imanaka N, Togawa T, Miyauchi M, Miyazaki M. Will subareolar injection be a standard technique for sentinel lymph node biopsy? Breast Cancer 2002; 9:319-322.
10. Maza S, Valencia R, Geworski L, Zander A, Guski H, Winzer KJ, Munz OL. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging 2003; 30:651-656.
11. Jansen L, Doting MH, Rutgers EJ, de Vries J, Olmos RA, Nieweg OE. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000; 87:920-925.
12. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867.
13. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38:366-368.
14. Upponi SS, McIntosh SA, Wishart GC, Balan KK, Purushotham AD. Sentinel lymph node biopsy in breast cancer-is lymphoscintigraphy really necessary? Eur J Surg Oncol 2002; 28:479-480.
15. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676-687.
16. Yeung HW, Cody IH, Turlakow A, Riedel ER, Fey J, Gonen M, et al. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med 2001; 42:420-423.
17. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999; 6:12-14.
18. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001; 233:51-59.